Meningitis and encephalitis

Karen Roos, John E. Greenlee

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose of Review: Neurologists have a vital role in the recognition of meningitis and encephalitis, the accurate evaluation and interpretation of CSF studies, and the management and prevention of the neurologic complications of CNS infectious diseases. Recent Findings: Although the tetravalent meningococcal glycoconjugate vaccine has decreased the incidence of meningococcal meningitis, the vaccine does not contain serogroup B, which is responsible for one-third of cases of meningococcal disease. Thus, meningitis due to Neisseria meningitidis is still a concern in a vaccinated individual. Empiric therapy for meningitis associated with sinusitis, otitis, or mastoiditis should include antibiotic therapy for anaerobes. An organism that classically causes a subacute or chronic meningitis, such as Mycobacterium tuberculosis, may on occasion present with an acute onset of symptoms. Summary: Unlike most other diseases, the management of patients with suspected meningitis or encephalitis begins with empiric therapy. The etiologic organism cannot always be identified. The goal is to identify those that are treatable, provide supportive care for those that are not, and, when possible, prevent the neurologic complications of these infections.

Original languageEnglish
Pages (from-to)1010-1023
Number of pages14
JournalContinuum (Minneapolis, Minn.)
Volume17
Issue number5
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Encephalitis
Meningitis
Meningococcal Vaccines
Nervous System
Mastoiditis
Meningococcal Meningitis
Otitis
Glycoconjugates
Neisseria meningitidis
Central Nervous System Diseases
Sinusitis
Disease Management
Mycobacterium tuberculosis
Communicable Diseases
Therapeutics
Anti-Bacterial Agents
Incidence
Infection

ASJC Scopus subject areas

  • Clinical Neurology
  • Genetics(clinical)

Cite this

Meningitis and encephalitis. / Roos, Karen; Greenlee, John E.

In: Continuum (Minneapolis, Minn.), Vol. 17, No. 5, 10.2011, p. 1010-1023.

Research output: Contribution to journalArticle

Roos, Karen ; Greenlee, John E. / Meningitis and encephalitis. In: Continuum (Minneapolis, Minn.). 2011 ; Vol. 17, No. 5. pp. 1010-1023.
@article{c72a846860af48f39b0c10ae4a56efdf,
title = "Meningitis and encephalitis",
abstract = "Purpose of Review: Neurologists have a vital role in the recognition of meningitis and encephalitis, the accurate evaluation and interpretation of CSF studies, and the management and prevention of the neurologic complications of CNS infectious diseases. Recent Findings: Although the tetravalent meningococcal glycoconjugate vaccine has decreased the incidence of meningococcal meningitis, the vaccine does not contain serogroup B, which is responsible for one-third of cases of meningococcal disease. Thus, meningitis due to Neisseria meningitidis is still a concern in a vaccinated individual. Empiric therapy for meningitis associated with sinusitis, otitis, or mastoiditis should include antibiotic therapy for anaerobes. An organism that classically causes a subacute or chronic meningitis, such as Mycobacterium tuberculosis, may on occasion present with an acute onset of symptoms. Summary: Unlike most other diseases, the management of patients with suspected meningitis or encephalitis begins with empiric therapy. The etiologic organism cannot always be identified. The goal is to identify those that are treatable, provide supportive care for those that are not, and, when possible, prevent the neurologic complications of these infections.",
author = "Karen Roos and Greenlee, {John E.}",
year = "2011",
month = "10",
doi = "10.1212/01.CON.0000407057.02414.a9",
language = "English",
volume = "17",
pages = "1010--1023",
journal = "CONTINUUM Lifelong Learning in Neurology",
issn = "1080-2371",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Meningitis and encephalitis

AU - Roos, Karen

AU - Greenlee, John E.

PY - 2011/10

Y1 - 2011/10

N2 - Purpose of Review: Neurologists have a vital role in the recognition of meningitis and encephalitis, the accurate evaluation and interpretation of CSF studies, and the management and prevention of the neurologic complications of CNS infectious diseases. Recent Findings: Although the tetravalent meningococcal glycoconjugate vaccine has decreased the incidence of meningococcal meningitis, the vaccine does not contain serogroup B, which is responsible for one-third of cases of meningococcal disease. Thus, meningitis due to Neisseria meningitidis is still a concern in a vaccinated individual. Empiric therapy for meningitis associated with sinusitis, otitis, or mastoiditis should include antibiotic therapy for anaerobes. An organism that classically causes a subacute or chronic meningitis, such as Mycobacterium tuberculosis, may on occasion present with an acute onset of symptoms. Summary: Unlike most other diseases, the management of patients with suspected meningitis or encephalitis begins with empiric therapy. The etiologic organism cannot always be identified. The goal is to identify those that are treatable, provide supportive care for those that are not, and, when possible, prevent the neurologic complications of these infections.

AB - Purpose of Review: Neurologists have a vital role in the recognition of meningitis and encephalitis, the accurate evaluation and interpretation of CSF studies, and the management and prevention of the neurologic complications of CNS infectious diseases. Recent Findings: Although the tetravalent meningococcal glycoconjugate vaccine has decreased the incidence of meningococcal meningitis, the vaccine does not contain serogroup B, which is responsible for one-third of cases of meningococcal disease. Thus, meningitis due to Neisseria meningitidis is still a concern in a vaccinated individual. Empiric therapy for meningitis associated with sinusitis, otitis, or mastoiditis should include antibiotic therapy for anaerobes. An organism that classically causes a subacute or chronic meningitis, such as Mycobacterium tuberculosis, may on occasion present with an acute onset of symptoms. Summary: Unlike most other diseases, the management of patients with suspected meningitis or encephalitis begins with empiric therapy. The etiologic organism cannot always be identified. The goal is to identify those that are treatable, provide supportive care for those that are not, and, when possible, prevent the neurologic complications of these infections.

UR - http://www.scopus.com/inward/record.url?scp=80053587352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053587352&partnerID=8YFLogxK

U2 - 10.1212/01.CON.0000407057.02414.a9

DO - 10.1212/01.CON.0000407057.02414.a9

M3 - Article

VL - 17

SP - 1010

EP - 1023

JO - CONTINUUM Lifelong Learning in Neurology

JF - CONTINUUM Lifelong Learning in Neurology

SN - 1080-2371

IS - 5

ER -